Literature DB >> 28591864

Optimism, pessimism and self-efficacy in female cancer patients.

Maik Thieme1, Jens Einenkel2, Markus Zenger3,4, Andreas Hinz1.   

Abstract

OBJECTIVE: The aim of this examination was to study whether psychological resource variables (optimism and self-efficacy) decrease when cancer is present and to test the predictive power of these variables for anxiety, depression and quality of life (QoL).
METHODS: The patient sample was comprised of 354 German women suffering from breast cancer or gynecological cancer. Participants filled in the resource assessment tools Life Orientation Test-Revised and the General Self-Efficacy Scale as well as the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire-4 and the QoL instrument EORTC QLQ-C30 at two time points: (t1) during patients' hospital stay and (t2) 3 months later.
RESULTS: The mean scores for optimism (total score: M = 16.2) and self-efficacy (M = 29.8) were even somewhat higher than the corresponding means of the general population. Optimism and self-efficacy were positively correlated with QoL (r between 0.15 and 0.17, P < 0.01) and negatively associated with anxiety and depression (r between -0.17 and -0.36, P < 0.01). However, only optimism was predictive of the t2 anxiety, depression and QoL scores when statistically taking into account the baseline levels of the outcome variables.
CONCLUSIONS: Having cancer does not generally reduce optimism and self-efficacy on the level of patients' mean scores. Cancer patients with a high level of habitual optimism will adapt to their disease better than pessimistic patients, even if the baseline levels of the outcome variables have been accounted for.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  cancer; mental health; optimism; quality of life

Mesh:

Year:  2017        PMID: 28591864     DOI: 10.1093/jjco/hyx079

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  7 in total

1.  Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels.

Authors:  Fei Wang; Xuejun Zhao; Wenhua Tan; Wei Liu; Yuxia Jin; Qian Liu
Journal:  PeerJ       Date:  2018-11-07       Impact factor: 2.984

2.  Temporal stability of quality of life assessments in cancer patients.

Authors:  Andreas Hinz; Thomas Schulte; Jörg Rassler; Markus Zenger; Kristina Geue
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

3.  The Influence of a Psychosocial Rehabilitation Program in a Community Health Setting for Patients with Chronic Mental Disorders.

Authors:  Paweł Rasmus; Anna Lipert; Krzysztof Pękala; Małgorzata Timler; Elżbieta Kozłowska; Katarzyna Robaczyńska; Tomasz Sobów; Remigiusz Kozłowski; Michał Marczak; Dariusz Timler
Journal:  Int J Environ Res Public Health       Date:  2021-04-19       Impact factor: 3.390

4.  The Correlation Between Quality of Life and Positive Psychological Resources in Cancer Patients: A Meta-Analysis.

Authors:  Xinxin Zhao; Siqi Tong; Ye Yang
Journal:  Front Psychol       Date:  2022-06-16

5.  Self-efficacy in relation to the use of complementary and alternative medicine, lifestyle choices and cancer aetiology.

Authors:  Lena Josfeld; Lara Krüger; Jens Büntzel; Bijan Zomorodbakhsch; Jutta Hübner
Journal:  J Cancer Res Clin Oncol       Date:  2021-11-23       Impact factor: 4.322

6.  Person-centred support programme (RESPECT intervention) for women with breast cancer treated with endocrine therapy: a feasibility study.

Authors:  Susanne Ahlstedt Karlsson; Ingela Henoch; Roger Olofsson Bagge; Catarina Wallengren
Journal:  BMJ Open       Date:  2022-10-05       Impact factor: 3.006

7.  Quality of life in breast cancer patients: Associations with optimism and social support.

Authors:  Carolyn Finck; Susana Barradas; Markus Zenger; Andreas Hinz
Journal:  Int J Clin Health Psychol       Date:  2017-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.